Mammogram order study for breast cancer survivors
Part of Cancer, Skin clinical trials.
This trial tests if changing the order of mammogram views makes the exam more comfortable for women who have had breast cancer surgery and radiation. You may be able to join if you are due for your first check-up mammogram after finishing treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You had breast cancer treated with lumpectomy (wide local excision)
- You finished surgery and radiation and are now due for your first yearly mammogram
- It has been less than 5 years since you completed breast cancer treatment
- You are willing and able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different imaging schedules after breast-conserving surgery for people with a higher risk of recurrence. It tests whether more frequent or different types of scans can catch any return of cancer earlier.
This study looks at how often older breast cancer survivors (80+) should get mammograms. It aims to make screening more personalized so women get the right amount of imaging.
This trial looks at whether having breast implants changes what happens during routine breast cancer screening with mammograms. It may help improve how screening is done and understood for people with implants.
This study tests whether getting a contrast-enhanced mammogram (CEM) every two years is effective for detecting breast cancer in women who have had breast cancer before. If you qualify, you will receive CEM instead of a standard mammogram to see if it helps find cancer earlier.
This study tests a new type of mammogram that might give clearer pictures of breast tissue. It is for women who are either scheduled for breast surgery or getting a regular mammogram.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.